phenelzine has been researched along with Recrudescence in 30 studies
Phenelzine: One of the MONOAMINE OXIDASE INHIBITORS used to treat DEPRESSION; PHOBIC DISORDERS; and PANIC.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Up to a third of elderly patients with major depressive disorder do not respond to a first course of treatment with an antidepressant." | 2.73 | Lithium augmentation compared with phenelzine in treatment-resistant depression in the elderly: an open, randomized, controlled trial. ( Heeren, TJ; Kok, RM; Nolen, WA; Vink, D, 2007) |
| "Differences in recurrence rates after the switch to placebo from phenelzine and imipramine could be due to the two drugs' different mechanisms of action or to baseline differences in the two populations." | 2.68 | Prophylactic efficacy of phenelzine and imipramine in chronic atypical depression: likelihood of recurrence on discontinuation after 6 months' remission. ( McGrath, PJ; Quitkin, FM; Stewart, JW; Tricamo, E, 1997) |
| "Patients who failed to respond to sustained, adequate treatment with the tricyclic imipramine (mean maximum dosage = 260 mg/day) and interpersonal psychotherapy were withdrawn from imipramine and treated in a standardized, but open-label 6-week trial with either phenelzine (N = 4; 60 mg/day) or tranylcypromine (N = 36; mean = 38." | 2.67 | Treatment of imipramine-resistant recurrent depression, III: Efficacy of monoamine oxidase inhibitors. ( Frank, E; Hamer, T; Kupfer, DJ; Mallinger, AG; Thase, ME, 1992) |
| "Endogenous anxiety (anxiety hysteria, agoraphobia with panic attacks) is characterized by sudden, spontaneous panic attacks accompanied by multiple autonomic symptoms, overwhelming fear, a flight response, and polyphobic behavior." | 2.65 | Treatment of endogenous anxiety with phobic, hysterical, and hypochondriacal symptoms. ( Ballenger, J; Jacobsen, G; Sheehan, DV, 1980) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 13 (43.33) | 18.7374 |
| 1990's | 11 (36.67) | 18.2507 |
| 2000's | 6 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lattanzi, L | 1 |
| Danesi, R | 1 |
| Lastella, M | 1 |
| Mungai, F | 1 |
| Di Paolo, A | 1 |
| Tuccori, M | 1 |
| Cassano, GB | 1 |
| Del Tacca, M | 1 |
| Vittengl, JR | 1 |
| Clark, LA | 1 |
| Jarrett, RB | 1 |
| Kok, RM | 1 |
| Vink, D | 1 |
| Heeren, TJ | 1 |
| Nolen, WA | 1 |
| Stewart, JT | 1 |
| Tyrer, P | 1 |
| Martin, CA | 1 |
| Iwamoto, ET | 1 |
| Sheehan, DV | 1 |
| Ballenger, J | 1 |
| Jacobsen, G | 1 |
| Serfaty, MA | 1 |
| McCluskey, S | 1 |
| Eccleston, D | 1 |
| Stewart, JW | 2 |
| Tricamo, E | 2 |
| McGrath, PJ | 2 |
| Quitkin, FM | 1 |
| Flint, AJ | 4 |
| Rifat, SL | 4 |
| Liebowitz, MR | 2 |
| Heimberg, RG | 1 |
| Schneier, FR | 1 |
| Hope, DA | 1 |
| Davies, S | 1 |
| Holt, CS | 1 |
| Goetz, D | 1 |
| Juster, HR | 1 |
| Lin, SH | 1 |
| Bruch, MA | 1 |
| Marshall, RD | 1 |
| Klein, DF | 1 |
| Swann, AC | 1 |
| Bowden, CL | 1 |
| Rush, AJ | 1 |
| Rhoades, H | 1 |
| Rose, R | 1 |
| Kobes, R | 1 |
| Davidson, J | 1 |
| Raft, D | 1 |
| Freeman, C | 1 |
| Greenblatt, M | 1 |
| Ashcroft, GW | 1 |
| Versiani, M | 1 |
| Nardi, AE | 1 |
| Mundim, FD | 1 |
| Alves, AB | 1 |
| Amrein, R | 1 |
| Montgomery, SA | 1 |
| Zubieta, JK | 1 |
| Demitrack, MA | 1 |
| Thase, ME | 1 |
| Frank, E | 1 |
| Mallinger, AG | 1 |
| Hamer, T | 1 |
| Kupfer, DJ | 1 |
| Aizenberg, D | 1 |
| Schwartz, B | 1 |
| Zemishlany, Z | 1 |
| Georgotas, A | 2 |
| McCue, RE | 2 |
| Cooper, TB | 2 |
| Donaldson, SR | 1 |
| Wesner, RB | 1 |
| Noyes, R | 1 |
| Nagachandran, N | 1 |
| Chang, I | 1 |
| Harrison, W | 1 |
| Rabkin, J | 1 |
| Quitkin, F | 1 |
| Solyom, L | 1 |
| Heseltine, GF | 1 |
| McClure, DJ | 1 |
| Solyom, C | 1 |
| Ledwidge, B | 1 |
| Steinberg, G | 1 |
| Raskin, A | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Characterization of the Molecular-Genetic Mechanisms Associated With Chemotherapy-Induced Peripheral Neuropathy Progression[NCT01293851] | 3 participants (Actual) | Observational | 2010-12-22 | Terminated | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for phenelzine and Recrudescence
| Article | Year |
|---|---|
Efficacy of ECT in affective and schizophrenic illness.
Topics: Amitriptyline; Chlorpromazine; Depression; Electroconvulsive Therapy; Evaluation Studies as Topic; H | 1977 |
12 trials available for phenelzine and Recrudescence
| Article | Year |
|---|---|
Validity of sudden gains in acute phase treatment of depression.
Topics: Acute Disease; Adult; Antidepressive Agents; Attitude; Awareness; Cognitive Behavioral Therapy; Comb | 2005 |
Lithium augmentation compared with phenelzine in treatment-resistant depression in the elderly: an open, randomized, controlled trial.
Topics: Aged; Antidepressive Agents; Antidepressive Agents, Tricyclic; Cyclohexanols; Depressive Disorder, M | 2007 |
Treatment of endogenous anxiety with phobic, hysterical, and hypochondriacal symptoms.
Topics: Adult; Anxiety; Depression; Double-Blind Method; Female; Humans; Hypochondriasis; Hysteria; Imiprami | 1980 |
Prophylactic efficacy of phenelzine and imipramine in chronic atypical depression: likelihood of recurrence on discontinuation after 6 months' remission.
Topics: Adult; Chronic Disease; Depressive Disorder; Drug Administration Schedule; Female; Humans; Imipramin | 1997 |
Recurrence of first-episode geriatric depression after discontinuation of maintenance antidepressants.
Topics: Aged; Antidepressive Agents; Depressive Disorder; Female; Follow-Up Studies; Humans; Male; Middle Ag | 1999 |
Desipramine versus phenelzine in recurrent unipolar depression: clinical characteristics and treatment response.
Topics: Adolescent; Adult; Aged; Antidepressive Agents, Tricyclic; Depressive Disorder; Desipramine; Female; | 1997 |
Pharmacotherapy of social phobia. A controlled study with moclobemide and phenelzine.
Topics: Adult; Benzamides; Comorbidity; Double-Blind Method; Female; Humans; Male; Middle Aged; Moclobemide; | 1992 |
Treatment of imipramine-resistant recurrent depression, III: Efficacy of monoamine oxidase inhibitors.
Topics: Adult; Animals; Clinical Protocols; Combined Modality Therapy; Depressive Disorder; Female; Humans; | 1992 |
A placebo-controlled comparison of nortriptyline and phenelzine in maintenance therapy of elderly depressed patients.
Topics: Aged; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Nort | 1989 |
How effective and safe is continuation therapy in elderly depressed patients? Factors affecting relapse rate.
Topics: Age Factors; Aged; Depressive Disorder; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nortri | 1988 |
Phenelzine for chronic depression: a study of continuation treatment.
Topics: Chronic Disease; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Female; Humans; | 1986 |
Behaviour therapy versus drug therapy in the treatment of phobic neurosis.
Topics: Adult; Anxiety; Aversive Therapy; Behavior Therapy; Electroshock; Evaluation Studies as Topic; Femal | 1973 |
17 other studies available for phenelzine and Recrudescence
| Article | Year |
|---|---|
Serotonin syndrome and the T102-->C polymorphism of the 5-HT2A receptor: a case report.
Topics: Adult; Alleles; Antidepressive Agents; Bipolar Disorder; Diagnosis, Differential; Dose-Response Rela | 2008 |
Not all monoamine oxidase inhibitors are created equal.
Topics: Aged; Aged, 80 and over; Antidepressive Agents; Combined Modality Therapy; Depressive Disorder, Majo | 2007 |
Clinical effects of abrupt withdrawal from tri-cyclic antidepressants and monoamine oxidase inhibitors after long-term treatment.
Topics: Adult; Antidepressive Agents, Tricyclic; Anxiety Disorders; Depressive Disorder; Female; Humans; Mal | 1984 |
Diethylpropion-induced psychosis reprecipitated by an MAO inhibitor: case report.
Topics: Adult; Diethylpropion; Female; Humans; Phenelzine; Psychoses, Substance-Induced; Recurrence; Substan | 1984 |
Extreme suicidality following serotonin syndrome.
Topics: Adolescent; Antidepressive Agents; Clomipramine; Depressive Disorder; Dothiepin; Drug Administration | 1995 |
Two-year outcome of elderly patients with anxious depression.
Topics: Aged; Antidepressive Agents; Anxiety Disorders; Depressive Disorder; Dose-Response Relationship, Dru | 1997 |
Cognitive-behavioral group therapy versus phenelzine in social phobia: long-term outcome.
Topics: Adult; Analysis of Variance; Chi-Square Distribution; Cognitive Behavioral Therapy; Confounding Fact | 1999 |
Maintenance treatment for recurrent depression in late life. A four-year outcome study.
Topics: Aged; Antidepressive Agents; Combined Modality Therapy; Depressive Disorder, Major; Drug Therapy, Co | 2000 |
Nonresponse to first-line pharmacotherapy may predict relapse and recurrence of remitted geriatric depression.
Topics: Aged; Aged, 80 and over; Antidepressive Agents; Antidepressive Agents, Tricyclic; Depressive Disorde | 2001 |
Single case study. Complementary effects of phenelzine and psychotherapy in long term treatment of depression.
Topics: Adult; Blood Platelets; Depression; Female; Humans; Long-Term Care; Monoamine Oxidase; Phenelzine; P | 1979 |
Psychological medicine. Management of depression.
Topics: Amitriptyline; Antidepressive Agents; Anxiety; Clomipramine; Depression; Drug Interactions; Electroc | 1975 |
Long-term treatment with SSRIs.
Topics: Depressive Disorder; Humans; Phenelzine; Recurrence; Serotonin Antagonists | 1992 |
Depression after cyproheptadine: MAO treatment.
Topics: Adult; Antidepressive Agents; Cyproheptadine; Depressive Disorder; Humans; Male; Phenelzine; Recurre | 1992 |
Delusional parasitosis associated with phenelzine.
Topics: Aged; Delusions; Depressive Disorder; Ectoparasitic Infestations; Female; Humans; Phenelzine; Psycho | 1991 |
Tolerance to phenelzine and subsequent refractory depression: three cases.
Topics: Adult; Chronic Disease; Depressive Disorder; Drug Tolerance; Female; Humans; Male; Middle Aged; Phen | 1989 |
Tolerance to the therapeutic effect of phenelzine in patients with panic disorder.
Topics: Adult; Animals; Anxiety Disorders; Drug Tolerance; Fear; Female; Humans; Male; Middle Aged; Panic; P | 1988 |
Age-sex differences in response to antidepressant drugs.
Topics: Adjustment Disorders; Adolescent; Adult; Age Factors; Aged; Antidepressive Agents; Anxiety; Chlorpro | 1974 |